Webinar: Best practices on INTERACTIVE RESPONSE TECHNOLOGY (IRT) and Clinical Su
Sign up to be notified of new teleseminars daily! |
| Description: | Join #DDi's online #Webinar on #IRT and #Clinical #Supply Chain Best Practices by Kate Chapman Former Associate Director, #IRT Services, #Shire Pharmaceuticals IRT systems are critical to correct randomization and efficient drug supply management but too often they are an afterthought for a team juggling many conflicting priorities. With a little careful preparation, and an efficient internal process, IRT development can be achieved in a streamlined fashion delivering an optimum IRT system with a fraction of the customary frustration and duplication of effort. Watch the DDi webinar by Kate Chapman, former Director Shire Pharmaceuticals. The IRT webinar will cover these points: Appreciating the importance of IRT Understanding your own organization An analysis of previous approaches and the implications thereof Discussion of best practices DDi has come up with the IRT tool named as mIRT.For companies looking for a sophisticated randomization and clinical supply chain management solutions, mIRT brings in greater value through its interactive response technology offering voice and web based system in an integrated platform. Key Features of DDi's IRT tool mIRT includes Randomization, Clinical Supplies, Study Management, Site Management and patient Management. Date/ Time: 29 Sept. 2016 I 10 - 11 a.m EST Click here to register : http://www.ddismart.com/registration-for-webinar-on-best-practices-on-irt-and-clinical-supplies-management |
| URL: | http://www.ddismart.com/live-webinar-on-best-practices-on-irt-and-clinical-supplies-management |
| Date: | Thursday, September 29, 2016 |
| Time: | 2:00pm-3:00pm UTC |
| Duration: | 1 hour |
| Access: | Public |
| Category: | Health*, Technology*, Webinar* |
| Created by: | Public Access |
| Updated: | Tuesday, September 13, 2016 9:28am UTC |
| : | 0 |
| : | 8778771519 |
| : | danielchristopher147@gmail.com |
| : | danielchristopher |
| : | |
| Comments: | None |